Comerica Bank
AMRX icon

Comerica Bank’s Amneal Pharmaceuticals AMRX Stock Holding History

Comerica Bank’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$59.1K Buy
4,690
+1,685
+56% +$19.3K ﹤0.01% 2797
2025
Q3 		$30.1K Buy
3,005
+1,957
+187% +$17.6K ﹤0.01% 2995
2025
Q2 		$8.48K Sell
1,048
-94
-8% -$709 ﹤0.01% 3252
2025
Q1 		$9.57K Buy
1,142
+157
+16% +$1.31K ﹤0.01% 3186
2024
Q4 		$7.8K Sell
985
-128
-12% -$1.07K ﹤0.01% 3229
2024
Q3 		$9.26K Buy
1,113
+182
+20% +$1.42K ﹤0.01% 3205
2024
Q2 		$5.91K Buy
931
+27
+3% +$171 ﹤0.01% 3270
2024
Q1 		$5.48K Sell
904
-350
-28% -$1.97K ﹤0.01% 3322
2023
Q4 		$7.61K Sell
1,254
-75
-6% -$334 ﹤0.01% 3219
2023
Q3 		$5.61K Buy
+1,329
New +$4.96K ﹤0.01% 3332

Other funds holding AMRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Comerica Bank's AMRX Position: Q4 2025 in Review

Comerica Bank increased its Amneal Pharmaceuticals (AMRX) stake by 56% in Q4 2025, buying an estimated $19.3K and bringing the position to 4,690 shares worth $59.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2797.

Comerica Bank first reported a position in AMRX in Q3 2023 and has held it in 10 quarters since. 277 funds tracked by Wall St. Rank hold AMRX as of Q4 2025.

  • Comerica Bank held 4,690 shares of Amneal Pharmaceuticals worth $59.1K as of Q4 2025.
  • Comerica Bank bought 1,685 Amneal Pharmaceuticals shares in Q4 2025, an estimated $19.3K.
  • Amneal Pharmaceuticals made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #2797 holding.
  • Comerica Bank first reported a position in Amneal Pharmaceuticals in Q3 2023 and has held it in 10 quarters since.
  • 277 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.